"Paraproteinemias" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A group of related diseases characterized by an unbalanced or disproportionate proliferation of immunoglobulin-producing cells, usually from a single clone. These cells frequently secrete a structurally homogeneous immunoglobulin (M-component) and/or an abnormal immunoglobulin.
| Descriptor ID |
D010265
|
| MeSH Number(s) |
C15.378.147.780 C20.683.780
|
| Concept/Terms |
Paraproteinemias- Paraproteinemias
- Paraproteinemia
- Paraimmunoglobulinemias
- Paraimmunoglobulinemia
Plasma Cell Dyscrasias- Plasma Cell Dyscrasias
- Cell Dyscrasia, Plasma
- Cell Dyscrasias, Plasma
- Dyscrasia, Plasma Cell
- Dyscrasias, Plasma Cell
- Plasma Cell Dyscrasia
Gammopathy, Monoclonal- Gammopathy, Monoclonal
- Gammopathies, Monoclonal
- Monoclonal Gammopathy
- Monoclonal Gammopathies
- Gammapathy, Monoclonal
- Gammapathies, Monoclonal
- Monoclonal Gammapathy
- Monoclonal Gammapathies
|
Below are MeSH descriptors whose meaning is more general than "Paraproteinemias".
Below are MeSH descriptors whose meaning is more specific than "Paraproteinemias".
This graph shows the total number of publications written about "Paraproteinemias" by people in this website by year, and whether "Paraproteinemias" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2003 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 4 | 0 | 4 |
| 2018 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2021 | 1 | 0 | 1 |
| 2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Paraproteinemias" by people in Profiles.
-
Enhancing prognostic power in multiple myeloma using a plasma cell signature derived from single-cell RNA sequencing. Blood Cancer J. 2024 03 06; 14(1):38.
-
The effects of short-term, progressive exercise training on disease activity in smouldering multiple myeloma and monoclonal gammopathy of undetermined significance: a single-arm pilot study. BMC Cancer. 2024 Feb 05; 24(1):174.
-
Genome-wide meta-analysis of monoclonal gammopathy of undetermined significance (MGUS) identifies risk loci impacting IRF-6. Blood Cancer J. 2022 04 13; 12(4):60.
-
Kidney Transplantation in Patients With Monoclonal Gammopathy of Renal Significance (MGRS)-Associated Lesions: A Case Series. Am J Kidney Dis. 2022 02; 79(2):202-216.
-
Clinicopathologic Assessment of Monoclonal Immunoglobulin-associated Renal Disease in the Kidney Allograft: A Retrospective Study and Review of the Literature. Transplantation. 2020 07; 104(7):1341-1349.
-
Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019 02; 95(2):281-295.
-
Crystal storing histiocytosis: Unusual clinical presentations in two patients. Ann Diagn Pathol. 2019 Jun; 40:13-17.
-
Primary Central Nervous System Lymphoma With Light Chain Deposition Disease (Aggregoma). J Neuroophthalmol. 2018 Jun; 38(2):195-197.
-
Antigen-mediated regulation in monoclonal gammopathies and myeloma. JCI Insight. 2018 04 19; 3(8).
-
Schnitzler syndrome in a patient with a family history of monoclonal gammopathy. Dermatol Online J. 2018 Jan 15; 24(1).